Retrospective analysis of a prospectively collected database of 170 patients between 2004 and 2020, who underwent liver resections for CRLM (colorectal liver metastases) at The Queen Elizabeth Hospital trying to determine rates and patterns of recurrence following liver resections for CRLM and concurrently, characterise clinical, pathological and treatment-related factors that could function as predictors of recurrence or survival, particularly neoadjuvant chemotherapy and tumour clearance.
This is a descriptive, observational study with retrospective analysis of a prospectively collated database. This database included all patients who underwent curative hepatic resections for CRLM (colorectal liver metastases) at The Queen Elizabeth Hospital (Adelaide, Australia) between December 2004 and October 2020.
Study Type
OBSERVATIONAL
Enrollment
170
Neoadjuvant treatment
Recurrence
Recurrence rate
Time frame: From surgery to recurrence, up to 16 years
Survival
up to16 years
Time frame: From surgery to death or end of the study, up to 16 years
Resection margins
Resection margins of the liver resection
Time frame: From surgery to death or end of the study, up to 16 years
Neoadjuvant Chemotherapy
Neoadjuvant Chemotherapy (yes or not)
Time frame: From surgery to death or end of the study, up to 16 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.